Andreas Dendorfer
Has participated in:
-
Optimierung der kardialen Programmierung von Stammzellen und der Reifung in vitro generierter Kardiomyozyten
-
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
-
Increased susceptibility of human endothelial cells to infections by SARS-CoV-2 variants
-
DNMT3A clonal hematopoiesis-driver mutations induce cardiac fibrosis by paracrine activation of fibroblasts